AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Disease Progression

Showing 401 to 410 of 704 articles

Clear Filters

Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning.

Alzheimer's & dementia : the journal of the Alzheimer's Association
INTRODUCTION: Developing cross-validated multi-biomarker models for the prediction of the rate of cognitive decline in Alzheimer's disease (AD) is a critical yet unmet clinical challenge.

Fitting prediction rule ensembles to psychological research data: An introduction and tutorial.

Psychological methods
Prediction rule ensembles (PREs) are a relatively new statistical learning method, which aim to strike a balance between predictive performance and interpretability. Starting from a decision tree ensemble, like a boosted tree ensemble or a random for...

Deep learning risk assessment models for predicting progression of radiographic medial joint space loss over a 48-MONTH follow-up period.

Osteoarthritis and cartilage
OBJECTIVE: To develop and evaluate deep learning (DL) risk assessment models for predicting the progression of radiographic medial joint space loss using baseline knee X-rays.

Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach.

Diabetes care
OBJECTIVE: To construct and internally validate prediction models to estimate the risk of long-term end-organ complications and mortality in patients with type 2 diabetes and obesity that can be used to inform treatment decisions for patients and pra...

Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.

NeuroImage. Clinical
Alzheimer's disease (AD) is characterised by a dynamic process of neurocognitive changes from normal cognition to mild cognitive impairment (MCI) and progression to dementia. However, not all individuals with MCI develop dementia. Predicting whether ...

Benchmarking Deep Learning Architectures for Predicting Readmission to the ICU and Describing Patients-at-Risk.

Scientific reports
To compare different deep learning architectures for predicting the risk of readmission within 30 days of discharge from the intensive care unit (ICU). The interpretability of attention-based models is leveraged to describe patients-at-risk. Several ...

A Novel Deep Learning Approach with a 3D Convolutional Ladder Network for Differential Diagnosis of Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
PURPOSE: Idiopathic normal pressure hydrocephalus (iNPH) and Alzheimer's disease (AD) are geriatric diseases and common causes of dementia. Recently, many studies on the segmentation, disease detection, or classification of MRI using deep learning ha...

Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson's disease.

Artificial intelligence in medicine
Tracking symptoms progression in the early stages of Parkinson's disease (PD) is a laborious endeavor as the disease can be expressed with vastly different phenotypes, forcing clinicians to follow a multi-parametric approach in patient evaluation, lo...

A survey on machine and statistical learning for longitudinal analysis of neuroimaging data in Alzheimer's disease.

Computer methods and programs in biomedicine
BACKGROUND AND OBJECTIVES: Recently, longitudinal studies of Alzheimer's disease have gathered a substantial amount of neuroimaging data. New methods are needed to successfully leverage and distill meaningful information on the progression of the dis...

DC-AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet.

Medical physics
PURPOSE: Pseudoprogression (PsP) occurs in 20-30% of patients with glioblastoma multiforme (GBM) after receiving the standard treatment. PsP exhibits similarities in shape and intensity to the true tumor progression (TTP) of GBM on the follow-up magn...